Parallel Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Sell |
5,375
-95
| -2% | -$28.2K | 0.03% | 346 |
|
|
2025
Q4 | $1.49M | Buy |
5,470
+134
| +3% | +$36.4K | 0.03% | 352 |
|
|
2025
Q3 | $1.44M | Buy |
5,336
+97
| +2% | +$26.4K | 0.03% | 347 |
|
|
2025
Q2 | $1.44M | Buy |
5,239
+303
| +6% | +$82.4K | 0.03% | 333 |
|
|
2025
Q1 | $1.31M | Buy |
4,936
+315
| +7% | +$77.7K | 0.03% | 337 |
|
|
2024
Q4 | $1.07M | Buy |
4,621
+786
| +20% | +$181K | 0.02% | 380 |
|
|
2024
Q3 | $846K | Sell |
3,835
-131
| -3% | -$27.1K | 0.02% | 426 |
|
|
2024
Q2 | $780K | Sell |
3,966
-344
| -8% | -$71.1K | 0.02% | 415 |
|
|
2024
Q1 | $928K | Buy |
4,310
+67
| +2% | +$14.1K | 0.03% | 383 |
|
|
2023
Q4 | $894K | Sell |
4,243
-44
| -1% | -$9.39K | 0.03% | 360 |
|
|
2023
Q3 | $858K | Buy |
4,287
+285
| +7% | +$56.7K | 0.03% | 343 |
|
|
2023
Q2 | $742K | Sell |
4,002
-137
| -3% | -$25.3K | 0.02% | 375 |
|
|
2023
Q1 | $793K | Buy |
4,139
+1,559
| +60% | +$282K | 0.03% | 351 |
|
|
2022
Q4 | $434K | Buy |
2,580
+150
| +6% | +$26.1K | 0.02% | 448 |
|
|
2022
Q3 | $430K | Sell |
2,430
-422
| -15% | -$83.4K | 0.02% | 429 |
|
|
2022
Q2 | $584K | Sell |
2,852
-309
| -10% | -$65.5K | 0.03% | 353 |
|
|
2022
Q1 | $764K | Buy |
3,161
+273
| +9% | +$64.1K | 0.03% | 321 |
|
|
2021
Q4 | $660K | Buy |
2,888
+444
| +18% | +$97.7K | 0.02% | 363 |
|
|
2021
Q3 | $473K | Buy |
2,444
+141
| +6% | +$28.6K | 0.02% | 417 |
|
|
2021
Q2 | $490K | Buy |
2,303
+360
| +19% | +$76K | 0.02% | 390 |
|
|
2021
Q1 | $397K | Buy |
1,943
+155
| +9% | +$30.5K | 0.02% | 416 |
|
|
2020
Q4 | $325K | Sell |
1,788
-348
| -16% | -$59.2K | 0.02% | 435 |
|
|
2020
Q3 | $357K | Sell |
2,136
-956
| -31% | -$161K | 0.02% | 379 |
|
|
2020
Q2 | $502K | Buy |
3,092
+40
| +1% | +$7.17K | 0.03% | 293 |
|
|
2020
Q1 | $527K | Sell |
3,052
-332
| -10% | -$66.1K | 0.04% | 233 |
|
|
2019
Q4 | $679K | Buy |
3,384
+40
| +1% | +$8.21K | 0.05% | 241 |
|
|
2019
Q3 | $707K | Buy |
3,344
+532
| +19% | +$111K | 0.06% | 218 |
|
|
2019
Q2 | $546K | Sell |
2,812
-57
| -2% | -$10.5K | 0.05% | 225 |
|
|
2019
Q1 | $472K | Buy |
2,869
+323
| +13% | +$57.1K | 0.05% | 228 |
|
|
2018
Q4 | $478K | Buy |
2,546
+90
| +4% | +$16.6K | 0.07% | 194 |
|
|
2018
Q3 | $418K | Buy |
2,456
+677
| +38% | +$114K | 0.05% | 236 |
|
|
2018
Q2 | $291K | Buy |
1,779
+27
| +2% | +$4.41K | 0.04% | 264 |
|
|
2018
Q1 | $283K | Sell |
1,752
-110
| -6% | -$17.5K | 0.04% | 262 |
|
|
2017
Q4 | $272K | Buy |
1,862
+682
| +58% | +$97.1K | 0.04% | 263 |
|
|
2017
Q3 | $165K | Sell |
1,180
-36
| -3% | -$4.55K | 0.03% | 357 |
|
|
2017
Q2 | $149K | Buy |
1,216
+132
| +12% | +$15.8K | 0.03% | 375 |
|
|
2017
Q1 | $128K | Buy |
1,084
+43
| +4% | +$5.17K | 0.03% | 389 |
|
|
2016
Q4 | $120K | Buy |
+1,041
| New | +$116K | 0.03% | 346 |
|
Other funds holding CME
VCM
VPM
Parallel Advisors's CME Position: Q1 2026 in Review
Parallel Advisors reduced its CME Group (CME) stake by 1.7% in Q1 2026, selling an estimated $28.2K and leaving 5,375 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #346.
Parallel Advisors first reported a position in CME in Q4 2016 and has held it in 38 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Parallel Advisors held 5,375 shares of CME Group worth $1.59M as of Q1 2026.
- Parallel Advisors sold 95 CME Group shares in Q1 2026, an estimated $28.2K.
- CME Group made up 0.03% of Parallel Advisors's portfolio in Q1 2026, its #346 holding.
- Parallel Advisors first reported a position in CME Group in Q4 2016 and has held it in 38 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.